Papargyri, N., Pontoppidan, M., Andersen, M. R., Koch, T., & Hagedorn, P. H. (2019). Chemical Diversity of Locked Nucleic Acid-Modified Antisense Oligonucleotides Allows Optimization of Pharmaceutical Properties. Mol Ther Nucleic Acids.

Papargyri, Natalia, Malene Pontoppidan, Mikael R. Andersen, Troels Koch, und Peter H. Hagedorn. "Chemical Diversity of Locked Nucleic Acid-Modified Antisense Oligonucleotides Allows Optimization of Pharmaceutical Properties." Mol Ther Nucleic Acids 2019.

Papargyri, Natalia, et al. "Chemical Diversity of Locked Nucleic Acid-Modified Antisense Oligonucleotides Allows Optimization of Pharmaceutical Properties." Mol Ther Nucleic Acids 2019.